631 related articles for article (PubMed ID: 20153649)
1. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer.
Hojo T; Nagao T; Kikuyama M; Akashi S; Kinoshita T
Breast; 2010 Jun; 19(3):210-3. PubMed ID: 20153649
[TBL] [Abstract][Full Text] [Related]
2. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
3. A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer.
Wishart GC; Loh SW; Jones L; Benson JR
Eur J Surg Oncol; 2012 Aug; 38(8):651-6. PubMed ID: 22704050
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the indocyanine green dye method versus the combined method of indigo carmine blue dye with indocyanine green fluorescence imaging for sentinel lymph node biopsy in breast conservative therapy for stage ≤IIA breast cancer.
Takemoto N; Koyanagi A; Yasuda M; Yamamoto H
BMC Womens Health; 2018 Sep; 18(1):151. PubMed ID: 30227837
[TBL] [Abstract][Full Text] [Related]
5. Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer.
Fujisawa Y; Nakamura Y; Kawachi Y; Otsuka F
J Surg Oncol; 2012 Jul; 106(1):41-5. PubMed ID: 22252373
[TBL] [Abstract][Full Text] [Related]
6. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
Foster D; Choy N; Porter C; Ahmed S; Wapnir I
J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
[TBL] [Abstract][Full Text] [Related]
7. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
[TBL] [Abstract][Full Text] [Related]
8. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study.
Guo J; Yang H; Wang S; Cao Y; Liu M; Xie F; Liu P; Zhou B; Tong F; Cheng L; Liu H; Wang S
World J Surg Oncol; 2017 Nov; 15(1):196. PubMed ID: 29096643
[TBL] [Abstract][Full Text] [Related]
9. Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer.
Lin J; Lin LS; Chen DR; Lin KJ; Wang YF; Chang YJ
Asian J Surg; 2020 Dec; 43(12):1149-1153. PubMed ID: 32143963
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence.
Murawa D; Hirche C; Dresel S; Hünerbein M
Br J Surg; 2009 Nov; 96(11):1289-94. PubMed ID: 19847873
[TBL] [Abstract][Full Text] [Related]
11. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy in breast cancer: an analysis of the maximum number of nodes requiring excision.
Gill J; Lovegrove R; Naessens K; Pursell R; Cominos T; McCormick C; Umeh H; Courtney S; Smith B
Breast J; 2011; 17(1):3-8. PubMed ID: 21129088
[TBL] [Abstract][Full Text] [Related]
13. A comparison of indocyanine green fluorescence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients.
Hirano A; Kamimura M; Ogura K; Kim N; Hattori A; Setoguchi Y; Okubo F; Inoue H; Miyamoto R; Kinoshita J; Fujibayashi M; Shimizu T
Ann Surg Oncol; 2012 Dec; 19(13):4112-6. PubMed ID: 22782671
[TBL] [Abstract][Full Text] [Related]
14. Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer.
Pitsinis V; Provenzano E; Kaklamanis L; Wishart GC; Benson JR
Surg Oncol; 2015 Dec; 24(4):375-9. PubMed ID: 26555151
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative detection of sentinel lymph nodes in breast cancer patients using ultrasonography-guided direct indocyanine green dye-marking by real-time virtual sonography constructed with three-dimensional computed tomography-lymphography.
Yamamoto S; Maeda N; Yoshimura K; Oka M
Breast; 2013 Oct; 22(5):933-7. PubMed ID: 23726129
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative Fluorescence Imaging for Sentinel Lymph Node Detection: Prospective Clinical Trial to Compare the Usefulness of Indocyanine Green vs Technetium Tc 99m for Identification of Sentinel Lymph Nodes.
Stoffels I; Dissemond J; Pöppel T; Schadendorf D; Klode J
JAMA Surg; 2015 Jul; 150(7):617-23. PubMed ID: 26017057
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
18. Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial.
Jung SY; Kim SK; Kim SW; Kwon Y; Lee ES; Kang HS; Ko KL; Shin KH; Lee KS; Park IH; Ro J; Jeong HJ; Joo J; Kang SH; Lee S
Ann Surg Oncol; 2014 Apr; 21(4):1254-9. PubMed ID: 24356798
[TBL] [Abstract][Full Text] [Related]
19. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic mapping with fluorescence navigation using indocyanine green and axillary surgery in patients with primary breast cancer.
Takeuchi M; Sugie T; Abdelazeem K; Kato H; Shinkura N; Takada M; Yamashiro H; Ueno T; Toi M
Breast J; 2012; 18(6):535-41. PubMed ID: 23009222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
